triamcinolone acetonide has been researched along with Glaucoma, Neovascular in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Degenring, RF; Jonas, JB; Kreissig, I | 1 |
Bonanomi, MT; Susanna, R | 1 |
Hayler, JK; Jonas, JB; Panda-Jonas, S; Söfker, A | 1 |
1 trial(s) available for triamcinolone acetonide and Glaucoma, Neovascular
Article | Year |
---|---|
Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone.
Topics: Aged; Aged, 80 and over; Crystallization; Diabetic Retinopathy; Female; Glaucoma, Neovascular; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris; Male; Middle Aged; Neovascularization, Pathologic; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2001 |
2 other study(ies) available for triamcinolone acetonide and Glaucoma, Neovascular
Article | Year |
---|---|
Neovascular glaucoma treated by intravitreal triamcinolone acetonide.
Topics: Aged; Glaucoma, Neovascular; Glucocorticoids; Humans; Injections; Middle Aged; Triamcinolone Acetonide; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide as adjunctive treatment for neovascular glaucoma.
Topics: Aged; Anti-Inflammatory Agents; Female; Glaucoma, Neovascular; Humans; Injections; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2005 |